Black Diamond Therapeutics, Inc. (BDTX) Tops Q1 EPS by 3c

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.

You May Also Be Interested In

• Strive Enterprises (ASST) Reiterated at Buy by StoneX on Launch of Digital Credit ETF
• Sphere adds 4D effects to Wizard of Oz show, topping $500M in sales
• Costco Wholesale (COST) PT Lowered to $1,143 at Bernstein SocGen Group